According to Mirati Therapeutics's latest financial reports the company's current earnings (TTM) are -HK$5.97 B. In 2022 the company made an earning of -HK$5.93 B a decrease over its 2021 earnings that were of -HK$4.47 B.The earnings displayed on this page is the company's Pretax Income.